-
Exploring the Link Between Self-Efficacy and Medication Adherence: Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail
Mar 10, 2025, 14:00 PM -
US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024
Mar 10, 2025, 14:00 PM -
Real-World Evidence in FDA Approvals for Labeling Extension of Drugs and Biologics
Mar 10, 2025, 14:00 PM -
The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab as Treatment for FIGO 2014 Stage III-IVA Cervical Cancer in the United States
Mar 10, 2025, 14:00 PM -
Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews
Mar 10, 2025, 14:00 PM -
Da Vinci Robotic-Assisted Surgery: 5 years of Health Technology Assessment Trends and Recommendations
Mar 10, 2025, 14:00 PM -
Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)
Mar 10, 2025, 14:00 PM -
GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers
Mar 10, 2025, 14:00 PM -
Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study
Mar 10, 2025, 14:00 PM -
Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision
Mar 10, 2025, 14:00 PM -
A Cost-Effectiveness Analysis of Diagnostic Testing in Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Cost-per-Event Analysis of Risankizumab in Comparison to Ustekinumab for the Treatment of Patients With Moderate-to-Severe Crohn’s Disease in Brazil
Mar 10, 2025, 14:00 PM -
Bridging the Gap between the NAPOLI 3 Trial and Real-World Practice: Real-World Overall Survival (OS) of First-Line (1L) FOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Mar 10, 2025, 14:00 PM -
Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study
Mar 10, 2025, 14:00 PM -
Socioeconomic Value of Targeted Therapies for HER2+ Breast Cancer in National Reimbursement Drug List of China
Mar 10, 2025, 14:00 PM -
Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer
Mar 10, 2025, 14:00 PM -
Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM
